Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Patent
1994-12-29
1997-12-23
Scheiner, Toni R.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
5303892, 5303911, 436518, C07K 122, G01N 3353
Patent
active
057009155
ABSTRACT:
Monoclonal antibodies are provided which are specific for human interleukin-4. Kits and methods are also provided for detecting, measuring and immunopurifying human interleukin-4, and for blocking the biological activity of human interleukin-4.
REFERENCES:
patent: 4311639 (1982-01-01), Ganfield et al.
patent: 4431739 (1984-02-01), Riggs
patent: 4474754 (1984-10-01), Shimizu et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4508830 (1985-04-01), Baker et al.
patent: 5013824 (1991-05-01), Abrams et al.
patent: 5017691 (1991-05-01), Lee et al.
patent: 5041381 (1991-08-01), Abrams et al.
J. Ohara et al., "Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1", Nature, vol. 315 (May 23rd 1985), pp. 333-336.
ATCC, ATCC Catalogue of Cell Lines & Hybridomas 5th Ed., p.228, 1985.
Berzofsky, Science, 229:932-940, 1985.
Ailsa M. Campbell, Monoclonal Antibody Technology, Elsevier Press, Ch. 1, 1984.
Farrar, et al., J. Immunol., 131:1838-1842, 1983.
F. D. Finkelman, et al., "Suppression of in Vivo Polyclonal IgE Responses by Monoclonal Antibody to the Lymphokine B-Cell Stimulatory Factor 1," PNAS USA 83:9675-9678, Dec. 1986.
Fraga, Can. J. Chem., 60:2606-2610, 1982.
Hopp, et al., PNAS, 78:3824-3828, 1981.
Howard, et al., Immunol. Rev., 78:185, 1984.
Kipps, et al., in Handbood of Exptl. Immunology, Weir, et al., Eds., Blackwell Sci. Publ., 4:108.1-108.9, 1986.
Lerner, et al., PNAS, 78:3404-3407, 1981.
Marx, Science, 226:819-821, 1984.
Mehta, et al., J. Immunol., 135:3298-3302, 1985.
Morrison, Science, 229:1202, 1985.
Novotny, et al., PNAS, 83:226-230, 1986.
O'Hara, et al., J. Immunol., 135:2518-2523, 1985.
J. Ohara, et al., "High-efficiency Purification and Chemical Characterization of B Cell Stimulatory Factor-1/Interleukin 4,"J. Immunol., 139:1127-1134, Aug.1987.
J. Ohara, et al., "Production of a Monoclonal Antibody to and Molecular Characterization of B Cell Stimulatory Factor-1," Biological Abstracts/RRM, 29:28715, 1985.
Palfreyman, et al., J. Immunol. Meth., 75:383-393, 1984.
Rabin, et al., PNAS, 82:2935-2939, 1985.
Roitsch, et al., Immunol. Meth., 3:85-109, 1985.
Sahasrabuddhe, et al., "Immune Regulation by Characterized Polypeptides U.C.L.A. Symp. Mol. & Cell Biology New Series," Goldstein, et al., Eds., Alan R. Uss Inc., 41:463-173, May 1987.
Sevier, et al., Clin. Chem., 27:1797-1806, 1981.
Sharma, et al., Science, 235:1489-1492, 1987.
Thompson, et al., J. Immunol., 134:369-474, 1985.
Walter, et al., Genetic Engineering, 5:61-91, 1983.
Westhof, et al., Nature, 371:123-125, 1984.
Williams, et al., in Handbook of Expt'l. Immunology, Weir, et al., Eds., Blackwell Sci. Publ., 1:22.1-22.24,1986.
Yokota, et al. PNAS USA, 83:5894-5898, 1986.
Campbell, AM Monoclonal Antibody Technology Elsevier Press, 1984.
Ohara et al. Nature 315: 333-336, 1985.
Yokota et al. PNAS 83:5894-98 1986.
Abrams John S.
Chretien Isabelle
Lee Frank D.
Pearce Michael K.
Ching Edwin P.
Grochala Richard J.
Scheiner Toni R.
Schering Corporations
LandOfFree
Human interleukin immunopurification processes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human interleukin immunopurification processes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human interleukin immunopurification processes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1803604